PMID- 25517305 OWN - NLM STAT- MEDLINE DCOM- 20150824 LR - 20211203 IS - 1942-0870 (Electronic) IS - 1942-0862 (Print) IS - 1942-0862 (Linking) VI - 6 IP - 5 DP - 2014 TI - Monomeric IgG1 Fc molecules displaying unique Fc receptor interactions that are exploitable to treat inflammation-mediated diseases. PG - 1201-10 LID - 10.4161/mabs.29835 [doi] AB - The IgG1 Fc is a dimeric protein that mediates important antibody effector functions by interacting with Fcgamma receptors (FcgammaRs) and the neonatal Fc receptor (FcRn). Here, we report the discovery of a monomeric IgG1 Fc (mFc) that bound to FcgammaRI with very high affinity, but not to FcgammaRIIIa, in contrast to wild-type (dimeric) Fc. The binding of mFc to FcRn was the same as that of dimeric Fc. To test whether the high-affinity binding to FcgammaRI can be used for targeting of toxins, a fusion protein of mFc with a 38 kDa Pseudomonas exotoxin A fragment (PE38), was generated. This fusion protein killed FcgammaRI-positive macrophage-like U937 cells but not FcgammaRI-negative cells, and mFc or PE38 alone had no killing activity. The lack of binding to FcgammaRIIIa resulted in the absence of Fc-mediated cytotoxicity of a scFv-mFc fusion protein targeting mesothelin. The pharmacokinetics of mFc in mice was very similar to that of dimeric Fc. The mFc's unique FcgammaRs binding pattern and related functionality, combined with its small size, monovalency and the preservation of FcRn binding which results in relatively long half-life in vivo, suggests that mFc has great potential as a component of therapeutics targeting inflammation mediated by activated macrophages overexpressing FcgammaRI and related diseases, including cancer. FAU - Ying, Tianlei AU - Ying T AD - a Key Laboratory of Medical Molecular Virology of Ministries of Education and Health; Shanghai Medical College ; Fudan University ; Shanghai , China. FAU - Feng, Yang AU - Feng Y FAU - Wang, Yanping AU - Wang Y FAU - Chen, Weizao AU - Chen W FAU - Dimitrov, Dimiter S AU - Dimitrov DS LA - eng GR - N01-CO-12400/CO/NCI NIH HHS/United States GR - Intramural NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, N.I.H., Intramural PL - United States TA - MAbs JT - mAbs JID - 101479829 RN - 0 (Antibodies, Monoclonal) RN - 0 (Bacterial Proteins) RN - 0 (Histocompatibility Antigens Class I) RN - 0 (Immunoconjugates) RN - 0 (Immunoglobulin Fc Fragments) RN - 0 (Immunoglobulin G) RN - 0 (Msln protein, mouse) RN - 0 (Receptors, Fc) RN - 0 (pseudomonas exoprotein A protein, Pseudomonas aeruginosa) RN - J27WDC343N (Mesothelin) RN - TW3XAW0RCY (Fc receptor, neonatal) SB - IM MH - Amino Acid Sequence MH - Animals MH - Antibodies, Monoclonal/immunology/metabolism/pharmacokinetics MH - Antibody-Dependent Cell Cytotoxicity/drug effects MH - Bacterial Proteins/chemistry/pharmacology MH - Cell Line MH - Cell Line, Tumor MH - Flow Cytometry MH - HEK293 Cells MH - Histocompatibility Antigens Class I/immunology/metabolism MH - Humans MH - Immunoconjugates/chemistry/pharmacology MH - Immunoglobulin Fc Fragments/chemistry/genetics/*immunology MH - Immunoglobulin G/*immunology/metabolism/pharmacology MH - Inflammation/drug therapy/*immunology/metabolism MH - Mesothelin MH - Mice MH - Molecular Sequence Data MH - Mutation MH - Protein Binding/immunology MH - Receptors, Fc/*immunology/metabolism MH - Sequence Homology, Amino Acid MH - U937 Cells PMC - PMC4622432 OTO - NOTNLM OT - ADCC OT - FcRn OT - Fcgamma receptors OT - chronic inflammation OT - monomeric Fc EDAT- 2014/12/18 06:00 MHDA- 2015/08/25 06:00 PMCR- 2015/10/30 CRDT- 2014/12/18 06:00 PHST- 2014/12/18 06:00 [entrez] PHST- 2014/12/18 06:00 [pubmed] PHST- 2015/08/25 06:00 [medline] PHST- 2015/10/30 00:00 [pmc-release] AID - 972751 [pii] AID - 10.4161/mabs.29835 [doi] PST - ppublish SO - MAbs. 2014;6(5):1201-10. doi: 10.4161/mabs.29835.